0001179110-21-000182.txt : 20210105
0001179110-21-000182.hdr.sgml : 20210105
20210105165713
ACCESSION NUMBER: 0001179110-21-000182
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210104
FILED AS OF DATE: 20210105
DATE AS OF CHANGE: 20210105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chen Hongming
CENTRAL INDEX KEY: 0001710697
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38150
FILM NUMBER: 21506709
MAIL ADDRESS:
STREET 1: 100 BEAVER STREET
STREET 2: SUITE 201
CITY: WALTHAM
STATE: MA
ZIP: 02453
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kala Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001479419
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270604595
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 120
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 781-996-5252
MAIL ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 120
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
edgar.xml
FORM 4 -
X0306
4
2021-01-04
0
0001479419
Kala Pharmaceuticals, Inc.
KALA
0001710697
Chen Hongming
C/O KALA PHARMACEUTICALS, INC.
490 ARSENAL WAY, SUITE 210
WATERTOWN
MA
02472
0
1
0
0
Chief Scientific Officer
Common Stock
2021-01-04
4
A
0
22666
0
A
186515
D
Stock Option (right to buy)
6.86
2021-01-04
4
A
0
90667
0
A
2031-01-03
Common Stock
90667
90667
D
Grant of restricted stock units ("RSUs") under the Issuer's 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued employment with Issuer, the RSUs will vest as to 1/3 of the shares underlying the RSUs on January 4, 2022, as to 1/3 of the shares underlying the RSUs on January 4, 2023 and as to the final 1/3 of shares underlying the RSUs on January 4, 2024.
Includes 99,666 unvested RSUs.
This option was granted on January 4, 2021 and vests with respect to 1/48th of the shares underlying the option at the end of each successive one-month period thereafter.
/s/ Eric Trachtenberg, Attorney-in-Fact
2021-01-05